Host Immune Defences & Immunotherapy
The global infectious immunology market is forecast to reach $8.8 billion by 2017, growing at a compound annual growth rate (CAGR) of 6% during the period 2010-2017. The hepatitis infections fragment developed at 7% and was esteemed at $2 billion in 2010.
Cell signaling is part of a complex system of communication that administers basic cellular activities and coordinates cell activities. A Neutralizing antibody is an antibody which safeguards a cell from an antigen or infectious body by inhibiting or neutralizing any effect it has biologically. Cell-mediated immunity is an immune response that does not involve antibodies, but rather involves the activation of phagocytes, antigen-specific cytotoxic T-lymphocytes, and the release of various cytokines in response to an antigen.
Immunotherapy, also called biologic therapy, is a type of cancer treatment designed to boost the body's natural defenses to fight the cancer. It uses materials either made by the body or in a laboratory to improve, target, or restore immune system function.
- Chemotherapy
- Radiotherapy
- Cellular immunotherapy
- Cancer immunotherapy
- Antibody therapy
- Cytokine therapy
- Immune system stimulation
- Acquired resistance
Related Conference of Host Immune Defences & Immunotherapy
Host Immune Defences & Immunotherapy Conference Speakers
Recommended Sessions
- Agriculture and plant virology
- Clinical & Neuro Virology
- Current Focus in Virology Research
- Drug discovery program
- HIV & Other Emerging Viruses affecting Afro-Asian Continents
- Host Immune Defences & Immunotherapy
- Pediatric Viral Diseases
- Recent Advances in Viral Therapy
- Therapeutic Approaches & Targets for Viral Infections
- Tumour Virology and Immunology
- Vaccines and Viral Vectors
- Veterinary Virology
- Viral Evolution & General Virology
- Viral hepatitis